The Journal of clinical endocrinology and metabolism

Differences between people in stomach emptying relate to GLP-1 hormone response after sugar enters the small intestine in healthy individuals

GLP-1 Therapies Weekly Brief ↗PubMed ↗DOI ↗OA ↗

Updated

Abstract

Gastric emptying of an oral glucose load may be related to the GLP-1 response to intestinal glucose exposure.

  • The relationship between gastric emptying and GLP-1 levels is being investigated.
  • GLP-1 is a hormone that plays a role in glucose metabolism.
  • Healthy individuals are the focus of this investigation.
  • Intestinal glucose exposure may influence GLP-1 secretion.

Simplified

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Sep '16
Leucine and isoleucine reduce blood sugar after a mixed meal in healthy lean people through different processes
cited by 37 papers
randomized controlled trial
Dec '25
Combined effects of lauric acid and L-tryptophan given into the small intestine on blood sugar, blood sugar control hormones, and stomach emptying after meals in type 2 diabetes
top 2% journal
journal article
Dec '24
Dose-dependent effects of quinine delivered into the small intestine on blood sugar, hormone levels, stomach emptying, and food intake in men with type 2 diabetes
top 2% journal
cited by 8 papers
randomized controlled trial
Dec '15
How meal order affects blood sugar, stomach emptying, and hormone release in type 2 diabetes
top 2% journal
cited by 97 papers
randomized controlled trial

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the glp-1 therapies brief

issue #48
Stop the drug, regain the weight: pooled data puts the average rebound at 7%
2 days ago7 studies
issue #47
The brain region that explains why blocking and activating the same receptor both cause weight loss
1 week ago7 studies
issue #46
GLP-1 drugs linked to lower depression and bipolar disorder risk in large genetic study
2 weeks ago7 studies
issue #45
Stopping GLP-1 drugs linked to higher depression and anxiety risk in type 2 diabetes patients
3 weeks ago7 studies
issue #44
Tirzepatide cut all-cause mortality by more than half compared to semaglutide in a 47,000-patient study
4 weeks ago7 studies
issue #43
Semaglutide linked to 21% lower psychiatric hospitalization risk in bipolar disorder patients
5 weeks ago7 studies
issue #42
Tirzepatide users lost 14.7% of body weight vs. 10.8% with semaglutide — but Black and Hispanic patients were overrepresented in the lowest-response group
6 weeks ago8 studies
issue #41
New obesity drug survodutide cut weight by 13% vs 5.4% for placebo in 725 patients
7 weeks ago7 studies
issue #40
GLP-1 users had 3x higher risk of aspiration pneumonia after stroke surgery
8 weeks ago7 studies
issue #39
Semaglutide linked to reduced cigarette craving in 24 smokers
9 weeks ago7 studies
explore the archive
See more issues from the glp-1 therapies brief